Project Description


MPA presents fairness opinion on a recapitalization transaction for an aggregate principal amount of US$3.8 billion.

More Information

About Concordia

Concordia is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, and sales in more than 90 countries. Going forward, the Company is focused on becoming a leader in European specialty, off-patent medicines.

Concordia operates out of facilities in Oakville, Ontario and, through its subsidiaries, operates out of facilities in Bridgetown, BarbadosLondon, England and Mumbai, India.

Click here for the news

Related Transactions

Load More Posts